200 related articles for article (PubMed ID: 15543763)
1. [Promoter methylation profile in breast cancer].
Roa JC; Anabalón L; Tapia O; Martínez J; Araya JC; Villaseca M; Guzmán P; Roa I
Rev Med Chil; 2004 Sep; 132(9):1069-77. PubMed ID: 15543763
[TBL] [Abstract][Full Text] [Related]
2. [Promoter methylation profile in gastric cancer].
Roa JC; Anabalón L; Roa I; Tapia O; Melo A; Villaseca M; Araya JC
Rev Med Chil; 2005 Aug; 133(8):874-80. PubMed ID: 16163424
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation profile in gallbladder cancer.
Roa JC; Anabalón L; Roa I; Melo A; Araya JC; Tapia O; de Aretxabala X; Muñoz S; Schneider B
J Gastroenterol; 2006 Mar; 41(3):269-75. PubMed ID: 16699861
[TBL] [Abstract][Full Text] [Related]
4. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
5. Methylation of E-cadherin and hMLH1 genes in Indian sporadic breast carcinomas.
Viswanathan M; Solomon SP; Tsuchida N; Selvam GS; Shanmugam G
Indian J Exp Biol; 2006 Feb; 44(2):115-9. PubMed ID: 16480176
[TBL] [Abstract][Full Text] [Related]
6. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H
J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837
[TBL] [Abstract][Full Text] [Related]
7. Relationship between point gene mutation, chromosomal abnormality, and tumour suppressor gene methylation status in colorectal adenomas.
Judson H; Stewart A; Leslie A; Pratt NR; Baty DU; Steele RJ; Carey FA
J Pathol; 2006 Nov; 210(3):344-50. PubMed ID: 16902913
[TBL] [Abstract][Full Text] [Related]
8. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines.
Lind GE; Thorstensen L; Løvig T; Meling GI; Hamelin R; Rognum TO; Esteller M; Lothe RA
Mol Cancer; 2004 Oct; 3():28. PubMed ID: 15476557
[TBL] [Abstract][Full Text] [Related]
9. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication.
Perri F; Cotugno R; Piepoli A; Merla A; Quitadamo M; Gentile A; Pilotto A; Annese V; Andriulli A
Am J Gastroenterol; 2007 Jul; 102(7):1361-71. PubMed ID: 17509026
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia.
Waki T; Tamura G; Tsuchiya T; Sato K; Nishizuka S; Motoyama T
Am J Pathol; 2002 Aug; 161(2):399-403. PubMed ID: 12163364
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene.
Cheng CW; Wu PE; Yu JC; Huang CS; Yue CT; Wu CW; Shen CY
Oncogene; 2001 Jun; 20(29):3814-23. PubMed ID: 11439345
[TBL] [Abstract][Full Text] [Related]
13. [Frequent promoter hypermethylation of several tumor suppressor genes in gastric carcinoma and foveolar epithelium].
Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):510-3. PubMed ID: 18069630
[TBL] [Abstract][Full Text] [Related]
14. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of DNA methylation status analyzed by bisulfite-PCR-SSCP and correlation with clinico-pathological characteristics in colorectal cancer.
Maekawa M; Sugano K; Ushiama M; Fukayama N; Nomoto K; Kashiwabara H; Fujita S; Kakizoe T
Clin Chem Lab Med; 2001 Feb; 39(2):121-8. PubMed ID: 11341745
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma.
Viswanathan M; Tsuchida N; Shanmugam G
Int J Cancer; 2003 May; 105(1):41-6. PubMed ID: 12672028
[TBL] [Abstract][Full Text] [Related]
18. Analysis of FHIT gene methylation in egyptian breast cancer women: association with clinicopathological features.
Zaki SM; Abdel-Azeez HA; El Nagar MR; Metwally KA; S Ahmed MM
Asian Pac J Cancer Prev; 2015; 16(3):1235-9. PubMed ID: 25735361
[TBL] [Abstract][Full Text] [Related]
19. [Promoter methylation of several tumor suppressor genes in human gastric adenocarcinoma].
Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):978-81. PubMed ID: 17650424
[TBL] [Abstract][Full Text] [Related]
20. [Gene methylation patterns in digestive tumors].
Roa S JC; García M P; Melo A A; Tapia E O; Villaseca H M; Araya O JC; Guzmán G P
Rev Med Chil; 2008 Apr; 136(4):451-8. PubMed ID: 18769787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]